Showing results (491-500 of 646) with videos related to
Sort By:
Pageof 65
Dermatology and Therapy|September 16, 2024
Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis RegistryAndrew Blauvelt, Robert R McLean, Silky W Beaty, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1985
Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonistD A Harris, G Van Vliet, C A Egli, et al.Nature Neuroscience|October 7, 2008
Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletionJun Mukai, Alefiya Dhilla, Liam J Drew, et al.Plos One|July 15, 2011
Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African AmericansHeather E Wheeler, Lidija K Gorsic, Marleen Welsh, et al.The Journal of Biological Chemistry|September 13, 1996
Ciliary neurotrophic factor induces down-regulation of its receptor and desensitization of signal transduction pathways in vivo: non-equivalence with pharmacological activityP S DiStefano, T G Boulton, J L Stark, et al.Journal of Clinical and Translational Science|May 5, 2021
Development and implementation of a community-based research networkBrittany C Minor, Jessica Dashner, Sandra M Espín Tello, et al.Environmental Management|November 2, 2004
Landscape character and fish assemblage structure and function in western Lake Superior streams: general relationships and identification of thresholdsJohn C Brazner, Danny K Tanner, Naomi E Detenbeck, et al.Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|October 25, 2024
Exploring the Remote Administration of a Performance-Based Functional AssessmentAudrey A Keleman, Rebecca M Bollinger, Juleen Rodakowski, et al.Journal of the American Academy of Dermatology|March 6, 2024
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trialsAndrew Blauvelt, April Armstrong, Joseph F Merola, et al.Archives of Physical Medicine and Rehabilitation|November 8, 2025
Process Evaluation of a Randomized Controlled Trial of an Enhanced Rehabilitation Transition Program for Stroke SurvivorsRebecca M Bollinger, Melissa J Krauss, Brianna M Holden, et al.Pageof 65